Shares of Anterix (ATEX) have gained 36.1% over the past four weeks to close the last trading session at $36.21, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $55.33 indicates a potential upside of 52.8%.The average comprises three short-term price targets ranging from a low of $44.00 to a high of $72.00, with a standard deviation of $14.74. While the lowest estimate indicates ...

Oscar Health, Inc. (OSCR) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this company have returned -8.5% over the past month versus the Zacks S&P 500 composite's +0.6% change. The Zacks Insurance - Multi line industry, to which Oscar Health belongs, has lost 0.6% over this period. Now the key question is: Where could the stock be headed in the near term?Although media repor ...

Arch Capital Group (ACGL) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this property and casualty insurer have returned +4.1% over the past month versus the Zacks S&P 500 composite's +0.6% change. The Zacks Insurance - Property and Casualty industry, to which Arch Capital belongs, has gained 4.3% over this period. Now the key question is: Where could t ...

Endeavour Silver (EXK) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -33.33%. A quarter ago, it was expected that this silver mining company would post earnings of $0.05 per share when it actually produced a loss of $0.01, delivering a surprise of -120%.Over the last four quarters, ...

inTest Corporation (INTT) came out with quarterly earnings of $0.16 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.23 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post earnings of $0.04 per share when it actually produced a loss of $0.02, delivering a surprise of -150%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.inTest, which belongs to the ...

分组1 - Northwest Natural (NWN) reported quarterly earnings of $1.39 per share, exceeding the Zacks Consensus Estimate of $1.36 per share, but down from $1.41 per share a year ago, representing an earnings surprise of +2.21% [1] - The company posted revenues of $394.16 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 0.21%, compared to year-ago revenues of $370.88 million [2] - Northwest Natural has surpassed consensus EPS estimates four times over the last four quarters, but has only topped consensus revenue estimates once during the same period [2] 分组2 - The stock has gained approximately 7.6% since the beginning of the year, outperforming the S&P 500's gain of 0.9% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for investors [4] - The current consensus EPS estimate for the coming quarter is $2.29 on revenues of $500.99 million, and $3.02 on revenues of $1.32 billion for the current fiscal year [7] 分组3 - The Zacks Industry Rank indicates that the Utility - Gas Distribution sector is currently in the bottom 34% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - The estimate revisions trend for Northwest Natural was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]

分组1 - Goldman Sachs BDC reported quarterly earnings of $0.37 per share, exceeding the Zacks Consensus Estimate of $0.36 per share, but down from $0.47 per share a year ago, representing an earnings surprise of +3.73% [1] - The company posted revenues of $86.06 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 2.09%, and down from $103.8 million year-over-year [2] - Over the last four quarters, Goldman Sachs BDC has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] 分组2 - The stock has underperformed the market, losing about 0.2% since the beginning of the year compared to the S&P 500's gain of 1.5% [3] - The current consensus EPS estimate for the coming quarter is $0.33 on revenues of $82.72 million, and for the current fiscal year, it is $1.31 on revenues of $317.79 million [7] - The Zacks Industry Rank for Financial - SBIC & Commercial Industry is currently in the bottom 41% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

分组1 - Cytek Biosciences reported a quarterly loss of $0.01 per share, missing the Zacks Consensus Estimate of $0.02, compared to earnings of $0.07 per share a year ago, resulting in an earnings surprise of -166.67% [1] - The company posted revenues of $62.14 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.23%, and showing an increase from year-ago revenues of $57.48 million [2] - Cytek Biosciences shares have declined approximately 13.5% since the beginning of the year, while the S&P 500 has gained 1.5% [3] 分组2 - The earnings outlook for Cytek Biosciences is mixed, with the current consensus EPS estimate for the coming quarter at -$0.04 on revenues of $44.44 million, and -$0.02 on revenues of $207.38 million for the current fiscal year [7] - The Medical - Biomedical and Genetics industry, to which Cytek belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

分组1 - AvePoint, Inc. reported quarterly earnings of $0.1 per share, exceeding the Zacks Consensus Estimate of $0.09 per share, compared to a loss of $0.04 per share a year ago, representing an earnings surprise of +11.11% [1] - The company posted revenues of $114.69 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 3.22%, and this is an increase from year-ago revenues of $89.18 million [2] - AvePoint has surpassed consensus EPS estimates three times and revenue estimates four times over the last four quarters [2] 分组2 - The stock has underperformed, losing about 26.4% since the beginning of the year, while the S&P 500 has gained 1.5% [3] - The current consensus EPS estimate for the coming quarter is $0.07 on revenues of $111.22 million, and for the current fiscal year, it is $0.38 on revenues of $490.38 million [7] - The Internet - Software industry, to which AvePoint belongs, is currently in the top 36% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

分组1 - Fidus Investment (FDUS) reported quarterly earnings of $0.52 per share, exceeding the Zacks Consensus Estimate of $0.48 per share, but down from $0.54 per share a year ago, representing an earnings surprise of +7.59% [1] - The company posted revenues of $42.15 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 5.86%, compared to year-ago revenues of $37.46 million [2] - Fidus Investment has surpassed consensus EPS estimates three times over the last four quarters and topped consensus revenue estimates four times during the same period [2] 分组2 - The stock has underperformed the market, losing about 4% since the beginning of the year, while the S&P 500 has gained 1.5% [3] - The current consensus EPS estimate for the coming quarter is $0.48 on revenues of $38.92 million, and for the current fiscal year, it is $1.92 on revenues of $160.16 million [7] - The Zacks Industry Rank for Financial - SBIC & Commercial Industry is currently in the bottom 41% of over 250 Zacks industries, indicating potential challenges for stock performance [8]